- This is the Clinical and Technical Assurance Sprint 4 pack is undergoing development in preparation for the first release within next 2 weeks).
- There will be disruption as the content will be updated daily and with links not working.
- Please follow the guidance on the "Contact Us" page if you need any assistance.
Clinical and Technical Assurance Sprint 4 Documentation Pack
Purpose
The purpose of this pack is to provide guidance documentation for people involved in the process of Clinical and Technical Assurance (C&TA) of Medicines.
The audiences of this documentation are internal NHS Digital programmes, external stakeholders and implementation sites using FHIR specifications. It is assumed that the reader has a basic understanding of HL7 FHIR.
Pack Structure
This pack contains the guidance and reference material required to participate in the Sprint 4 of C&TA. The content of the UK Core to be reviewed is contained in the HL7 FHIR® UK Core Profiles for R4 (Draft Standard for Trial Use). Items are indexed by C&TA Sprints and the scope of this sprint is items marked Sprint 4.
Associated Implementation Guides
Dose Syntax Implementation Guidance for FHIR R4 is also in scope of the Clinical and Technical Assurance Sprint 4.Background
This documentation is released as Sprint 4 of the FHIR clinical and technical assurance process. This sprint involves creating a review pack for external consultation, including a first draft of mapping by a core team which is published to the external community for a review period of 15 working days. This process is documented and is available in Simplifier. This C&TA process is a replacement for the curation process used for the FHIR STU3 CareConnect profiles. The documentation will give background information to allow the reader to take part in the C&TA process.
FHIR Training
If you require more training on HL7 FHIR, please watch the videos in Training.
|
|
|
|
|
|
|
|---|